Abstract
Effective intracellular expression of small RNA therapeutics depends on a number of factors. The RNA, whether antisense, ribozyme, or RNA aptamer, must be efficiently transcribed, stabilized against rapid degradation, folded correctly, and directed to the part of the cell where it can be most effective. To overcome a number of these problems we have been testing expression cassettes based on the human tRNAmet and U6 snRNA promoters, in which transcripts encoding small RNA inserts are protected against attack from the 3′ end. Transient expression in cultured cells results in 103–2 × 107 full-length transcripts per cell, depending partially on the promoter construct used but also on the nature of the insert RNA. 5′ γ-Phosphate methylation (capping) depended, as expected, on the inclusion of specific U6 snRNA sequences from positions +19 to +27. In situ localization of the transcripts shows that both tRNA and U6 promoter transcripts give primarily punctate nuclear patterns, and that capping of transcripts is not required for nuclear retention. Several different insert RNAs directed against HIV-1 were tested by cotransfection with HIV-1 provirus and assay for subsequent viral reverse transcriptase production. These include antisense RNA, hairpin and hammerhead ribozymes, and RNA ligands (aptamers) for Tat and Rev RNA binding proteins. Results show that Rev-binding RNAs efficiently block HIV-1 gene expression, whereas other RNAs have little or no effect when expressed in these cassettes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Good, P., Krikos, A., Li, S. et al. Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther 4, 45–54 (1997). https://doi.org/10.1038/sj.gt.3300354
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300354
Keywords
This article is cited by
-
Anti-cancer activity of ultra-short single-stranded polydeoxyribonucleotides
Investigational New Drugs (2023)
-
Genome editing with CRISPR/Cas9 in Pinus radiata (D. Don)
BMC Plant Biology (2021)
-
A dimerization-based fluorogenic dye-aptamer module for RNA imaging in live cells
Nature Chemical Biology (2020)
-
Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts
Nature Biotechnology (2019)
-
Targeting the polyadenylation factor EhCFIm25 with RNA aptamers controls survival in Entamoeba histolytica
Scientific Reports (2018)